Fyn is not essential for Bcr-Abl-induced leukemogenesis in mouse bone marrow transplantation models

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International journal of hematology

• Publication date

  2012-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12185-011-0994-5PMID 22189847
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Upregulation of CD200R1 in lineage-negative leukemic cells is characteristic of AML1-ETO-positive leukemia in mice

  2012cited by this paper
• Expression and Activity of Fyn Mediate Proliferation and Blastic Features of Chronic Myelogenous Leukemia

  2012cited by this paper
• Two types of C/EBPα mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models.

  2011cited by this paper
• Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia.

  2010cited by this paper
• Critical molecular pathways in cancer stem cells of chronic myeloid leukemia

  2010cited by this paper
• AML1 mutations induced MDS and MDS/AML in a mouse BMT model.

  2008cited by this paper
• BCR-ABL1 mediates up-regulation of Fyn in chronic myelogenous leukemia.

  2008cited by this paper
• Loss of Fyn tyrosine kinase on the C57BL/6 genetic background causes hydrocephalus with defects in oligodendrocyte development.

  2008cited by this paper
• Oncogenic signaling: new insights and controversies from chronic myeloid leukemia

  2007cited by this paper
• Src kinase signaling in leukaemia.

  2007cited by this paper
• Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice

  2006cited by this paper
• The Second Generation of BCR-ABL Tyrosine Kinase Inhibitors

  2006cited by this paper
• Gene expression changes associated with progression and response in chronic myeloid leukemia.

  2006cited by this paper
• Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1(+) leukemia cells

  2004cited by this paper
• Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia

  2004cited by this paper
• BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571.

  2003cited by this paper
• The influence of the src‐family kinases, Lck and Fyn, on T cell differentiation, survival and activation

  2003cited by this paper
• Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics.

  2003cited by this paper
• Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.

  2002cited by this paper
• Molecular Biology of Chronic Myeloid Leukemia

  2001cited by this paper
• Plat-E: an efficient and stable system for transient packaging of retroviruses

  2000cited by this paper
• Chronic myeloid leukemia.

  1999cited by this paper
• The Src Family Kinase Hck Interacts with Bcr-Abl by a Kinase-independent Mechanism and Phosphorylates the Grb2-binding Site of Bcr*

  1997cited by this paper
• Activation of Src kinases p53/56lyn and p59hck by p210bcr/abl in myeloid cells.

  1996cited by this paper
• Regional localization of Fyn in adult brain; studies with mice in which fyn gene was replaced by lacZ.

  1993cited by this paper

• Role of Fyn in hematological malignancies

  2023influential citation
• Advances in the expression and function of Fyn in different human tumors

  2023cites this paper
• Beyond TCR Signaling: Emerging Functions of Lck in Cancer and Immunotherapy

  2019cites this paper
• Hes1 promotes blast crisis in chronic myelogenous leukemia through MMP-9 upregulation in leukemic cells.

  2014cites this paper
• Upregulation of CD200R1 in lineage-negative leukemic cells is characteristic of AML1-ETO-positive leukemia in mice

  2012cites this paper
• Expression and Activity of Fyn Mediate Proliferation and Blastic Features of Chronic Myelogenous Leukemia

  2012cites this paper